Cargando…
Alterations of Fatty Acid Profile May Contribute to Dyslipidemia in Chronic Kidney Disease by Influencing Hepatocyte Metabolism
Chronic kidney disease (CKD) is associated with atherogenic dyslipidemia. Our aim was firstly to investigate patterns of fatty acids (FA) composition through various stages of CKD, and secondly, to evaluate the effect of CKD-specific FA disturbances on the expression of genes related to lipid metabo...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566623/ https://www.ncbi.nlm.nih.gov/pubmed/31109090 http://dx.doi.org/10.3390/ijms20102470 |
_version_ | 1783426890713792512 |
---|---|
author | Czumaj, Aleksandra Śledziński, Tomasz Carrero, Juan-Jesus Stepnowski, Piotr Sikorska-Wisniewska, Malgorzata Chmielewski, Michal Mika, Adriana |
author_facet | Czumaj, Aleksandra Śledziński, Tomasz Carrero, Juan-Jesus Stepnowski, Piotr Sikorska-Wisniewska, Malgorzata Chmielewski, Michal Mika, Adriana |
author_sort | Czumaj, Aleksandra |
collection | PubMed |
description | Chronic kidney disease (CKD) is associated with atherogenic dyslipidemia. Our aim was firstly to investigate patterns of fatty acids (FA) composition through various stages of CKD, and secondly, to evaluate the effect of CKD-specific FA disturbances on the expression of genes related to lipid metabolism at a cellular level. Serum FA composition was analyzed in 191 patients with consecutive severity stages of CKD, and 30 healthy controls free from CKD. Next, HepG2 human hepatic cells were treated with major representatives of various FA groups, as well as with FA extracted from a mix of serums of controls and of CKD stage 5 patients. Across worsening stages of CKD severity, there was an increasing monounsaturated FA (MUFA) content. It was associated with a concomitant decrease in n-3 and n-6 polyunsaturated FA. The incubation of hepatocytes with FA from CKD patients (compared to that of healthy subjects), resulted in significantly higher mRNA levels of genes involved in FA synthesis (fatty acid synthase (FASN) increased 13.7 ± 3.5 times, stearoyl-CoA desaturase 1 (SCD1) increased 4.26 ± 0.36 times), and very low density lipoprotein (VLDL) formation (apolipoprotein B (ApoB) increased 7.35 ± 1.5 times, microsomal triacylglycerol transfer protein (MTTP) increased 2.74 ± 0.43 times). In conclusion, there were progressive alterations in serum FA composition of patients with CKD. These alterations may partly contribute to CKD hypertriglyceridemia by influencing hepatocyte expression of genes of lipid synthesis and release. |
format | Online Article Text |
id | pubmed-6566623 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-65666232019-06-17 Alterations of Fatty Acid Profile May Contribute to Dyslipidemia in Chronic Kidney Disease by Influencing Hepatocyte Metabolism Czumaj, Aleksandra Śledziński, Tomasz Carrero, Juan-Jesus Stepnowski, Piotr Sikorska-Wisniewska, Malgorzata Chmielewski, Michal Mika, Adriana Int J Mol Sci Article Chronic kidney disease (CKD) is associated with atherogenic dyslipidemia. Our aim was firstly to investigate patterns of fatty acids (FA) composition through various stages of CKD, and secondly, to evaluate the effect of CKD-specific FA disturbances on the expression of genes related to lipid metabolism at a cellular level. Serum FA composition was analyzed in 191 patients with consecutive severity stages of CKD, and 30 healthy controls free from CKD. Next, HepG2 human hepatic cells were treated with major representatives of various FA groups, as well as with FA extracted from a mix of serums of controls and of CKD stage 5 patients. Across worsening stages of CKD severity, there was an increasing monounsaturated FA (MUFA) content. It was associated with a concomitant decrease in n-3 and n-6 polyunsaturated FA. The incubation of hepatocytes with FA from CKD patients (compared to that of healthy subjects), resulted in significantly higher mRNA levels of genes involved in FA synthesis (fatty acid synthase (FASN) increased 13.7 ± 3.5 times, stearoyl-CoA desaturase 1 (SCD1) increased 4.26 ± 0.36 times), and very low density lipoprotein (VLDL) formation (apolipoprotein B (ApoB) increased 7.35 ± 1.5 times, microsomal triacylglycerol transfer protein (MTTP) increased 2.74 ± 0.43 times). In conclusion, there were progressive alterations in serum FA composition of patients with CKD. These alterations may partly contribute to CKD hypertriglyceridemia by influencing hepatocyte expression of genes of lipid synthesis and release. MDPI 2019-05-18 /pmc/articles/PMC6566623/ /pubmed/31109090 http://dx.doi.org/10.3390/ijms20102470 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Czumaj, Aleksandra Śledziński, Tomasz Carrero, Juan-Jesus Stepnowski, Piotr Sikorska-Wisniewska, Malgorzata Chmielewski, Michal Mika, Adriana Alterations of Fatty Acid Profile May Contribute to Dyslipidemia in Chronic Kidney Disease by Influencing Hepatocyte Metabolism |
title | Alterations of Fatty Acid Profile May Contribute to Dyslipidemia in Chronic Kidney Disease by Influencing Hepatocyte Metabolism |
title_full | Alterations of Fatty Acid Profile May Contribute to Dyslipidemia in Chronic Kidney Disease by Influencing Hepatocyte Metabolism |
title_fullStr | Alterations of Fatty Acid Profile May Contribute to Dyslipidemia in Chronic Kidney Disease by Influencing Hepatocyte Metabolism |
title_full_unstemmed | Alterations of Fatty Acid Profile May Contribute to Dyslipidemia in Chronic Kidney Disease by Influencing Hepatocyte Metabolism |
title_short | Alterations of Fatty Acid Profile May Contribute to Dyslipidemia in Chronic Kidney Disease by Influencing Hepatocyte Metabolism |
title_sort | alterations of fatty acid profile may contribute to dyslipidemia in chronic kidney disease by influencing hepatocyte metabolism |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566623/ https://www.ncbi.nlm.nih.gov/pubmed/31109090 http://dx.doi.org/10.3390/ijms20102470 |
work_keys_str_mv | AT czumajaleksandra alterationsoffattyacidprofilemaycontributetodyslipidemiainchronickidneydiseasebyinfluencinghepatocytemetabolism AT sledzinskitomasz alterationsoffattyacidprofilemaycontributetodyslipidemiainchronickidneydiseasebyinfluencinghepatocytemetabolism AT carrerojuanjesus alterationsoffattyacidprofilemaycontributetodyslipidemiainchronickidneydiseasebyinfluencinghepatocytemetabolism AT stepnowskipiotr alterationsoffattyacidprofilemaycontributetodyslipidemiainchronickidneydiseasebyinfluencinghepatocytemetabolism AT sikorskawisniewskamalgorzata alterationsoffattyacidprofilemaycontributetodyslipidemiainchronickidneydiseasebyinfluencinghepatocytemetabolism AT chmielewskimichal alterationsoffattyacidprofilemaycontributetodyslipidemiainchronickidneydiseasebyinfluencinghepatocytemetabolism AT mikaadriana alterationsoffattyacidprofilemaycontributetodyslipidemiainchronickidneydiseasebyinfluencinghepatocytemetabolism |